Citations

Mayo Clinic

Clear

1994 citation(s) found for "Vu, Joshua".

381 Conservative Management of Suspected Fractures in Men Undergoing Collagenase Clostridium Histolyticum for Peyronie's Disease Is not Associated with Worsening of Erectile Function
Alom, M. , Trost, L., Sharma, Kiran , Bole, Raevti , Savage, Joshua S.

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S107-S107

10.1016/j.jsxm.2019.11.226 Get It

152 Multi-Center Experience Utilizing Collagen Fleece for Plaque Incision with Grafting to Correct Residual Curvature at Time of Inflatable Penile Prosthesis Placement in Peyronie's Disease Patients
Hatzichristodoulou, Georgios , Ring, Joshua , Ziegelmann, Matthew , Köhler, Tobias , Yang, David Y. , Hebert, Kevin

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S45-S46

10.1016/j.jsxm.2019.11.097 Get It

149 6-Month Outcomes of RestoreX Penile Traction Therapy in Men with Peyronie's Disease: A Randomized, Controlled Trial
Ziegelmann, M., Toussi, Amir , Alom, Mulham , Trost, L., Savage, Joshua S. , Sharma, Kiran

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S44-S44

10.1016/j.jsxm.2019.11.094 Get It

025 Efficacy of RestoreX Penile Traction Therapy in Improving Penile Length and Erectile Function Post Prostatectomy
Toussi, Amir , Alom, Mulham , Ziegelmann, Matthew , Trost, L., Savage, Joshua S. , Sharma, Kiran

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S13-S14

10.1016/j.jsxm.2019.11.027 Get It

013 Should Men with Poor Results After Two Series of Collagenase Injections for Peyronie’s Disease Continue Therapy?
Alom, Mulham , Ziegelmann, M., Köhler, Tobias , Trost, L., Sharma, Kiran , Savage, Joshua S.

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S6-S6

10.1016/j.jsxm.2019.11.016 Get It

Upper Extremity and Hip Range of Motion Changes Throughout a Season in Professional Baseball Players
Chan, Justin M., Zajac, John M., Altchek, David W. , Coleman, Struan H. , Camp, Christopher, Erickson, Brandon J. , Camp, Christopher L. , Dines, Joshua S.

The American Journal of Sports Medicine | December 31, 2019 | Volume: 48 | Issue: 2 | Pages: 481-487

10.1177/0363546519894567 | PMID 31891517 Get It

Background: Loss of upper and lower extremity range of motion (ROM) is a significant risk factor for injuries in professional baseball players. Purpose/Hypothesis: The purpose was to determine changes in ROM in professional baseball players over the course of a single season and their careers. We hypothesized that pitchers and position players would lose ROM, specifically total shoulder motion (total ROM [TROM]) and hip internal rotation (IR), over the course of a season and their careers. Study Design: Case series; Level of evidence, 4. Methods: Upper and lower extremity ROM measurements were recorded during pre-, mid-, and postseason on all professional baseball players for a single organization between 2011 and 2018. ROM measurements were compared for pitchers and position players over the course of the season and their careers. Also, ROM measurements over the pre-, mid-, and postseason were compared between pitchers and position players. Results: A total of 166 professional baseball players (98 pitchers, 68 position players) were included. Pitcher hip external rotation (ER; P < .001), IR ( P = .010), and TROM ( P < .001) for lead and trail legs decreased over the course of the season. Pitcher shoulder ER ( P = .005), TROM ( P = .042), and horizontal adduction ( P < .001) significantly increased over the course of the season. Position player shoulder flexion ( P = .046), hip ER ( P < .001, lead leg; P < .001, trail leg), and hip TROM ( P = .001; P = .002) decreased over the course of the season. Position player shoulder ER ( P = .031) and humeral adduction ( P < .001) significantly increased over the course of the season. Over the course of pitchers’ careers, there was decreased shoulder IR ( P = .014), increased shoulder horizontal adduction ( P < .001), and hip IR ( P = .042) and hip TROM ( P = .027) for the lead leg. Position players experienced loss of hip TROM ( P = .010, lead leg; P = .018, trail leg) over the course of their careers. Pitchers started with and maintained more shoulder ER and gained more shoulder TROM over a season as compared with position players. Conclusion: Pitchers and position players saw overall decreases in hip ROM but increases in shoulder ROM over the course of the season and career.
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients
Whitmire, Paula , Rickertsen, Cassandra , Lorence, Julia, León, Gustavo De , Bayless, Spencer, Clark-Swanson, Kamala , Corpuz, Christina, Angeles, Christine Paula Lewis-de los, Vora, Sujay A., Mrugała, Maciej M. , Hu, Leland , Porter, Alyx B. , Kumthekar, Priya , Johnston, Sandra K. , Egan, Kathleen M. , Canoll, Peter , Swanson, Kristin R. , Swanson, Kristin R , Hawkins‐Daarud, Andrea , Carrasco, Eduardo, Leon, Gustavo De, Curtin, Lee , Peeri, Noah Charles , Bendok, Bernard R. , Gonzalez‐Cuyar, Luis F. , Wang, Lei G. , Gatenby, Robert A. , Rubin, Joshua B

No container title available | December 19, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.10177/v3 Get It

Abstract Background : Sex is recognized as a significant determinant of outcome among glioblastoma patients, but the relative prognostic importance of glioblastoma features has not been thoroughly explored for sex differences. Methods : Combining multi-modal MR images, biomathematical models, and patient clinical information, this investigation assesses which pretreatment variables have a sex-specific impact on the survival of glioblastoma patients (299 males and 195 females). Results : Among males, tumor (T1Gd) radius was a predictor of overall survival (HR=1.027, p=0.044). Among females, higher tumor cell net invasion rate was a significant detriment to overall survival (HR=1.011, p<0.001). Female extreme survivors had significantly smaller tumors (T1Gd) (p=0.010 t-test), but tumor size was not correlated with female overall survival (p=0.955 CPH). Both male and female extreme survivors had significantly lower tumor cell net proliferation rates than other patients (M p=0.004, F p=0.001, t-test). Conclusion : Despite similar distributions of the MR imaging parameters between males and females, there was a sex-specific difference in how these parameters related to outcomes.
1351: ADVANCED PRACTICE PROVIDER FELLOWSHIP PROGRAM: SUPPORTING CRITICAL CARE CROSS-COVERAGE MODEL
Peacock, Sarah , Grek, Ami , Propst, Joshua, Ojard, Michelle, Lowman, Philip, Richie, Eugene

Critical Care Medicine | December 18, 2019 | Volume: 48 | Issue: 1 | Pages: 652-652

10.1097/01.ccm.0000645320.03984.dc Get It

1702: RIGHT ATRIAL PERFORATION PRESENTING AS TAMPONADE IMMEDIATELY POST-ORTHOTOPIC LIVER TRANSPLANTATION
Santos, Christan, Propst, Joshua, Goswami, Rohan , Canabal, Juan, Goswami, Rohan

Critical Care Medicine | December 18, 2019 | Volume: 48 | Issue: 1 | Pages: 826-826

10.1097/01.ccm.0000649108.86287.ee Get It

Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704
Reyngold, Marsha , Winter, Kathryn, Regine, William F., Abrams, Ross A. , Safran, Howard , Hoffman, John P., Mowat, Rex B., Kessel, Ivan L., DiPetrillo, Thomas A., Chen, Yuhchyau , Ben‐Josef, Edgar , Delouya, Guila , Haddock, Michael G. , Feldman, Marvin, Gaur, Rakesh , Yost, Kathleen J. , Peterson, Richard A. , Sherr, David L., Moughan, Jennifer, Crane, Christopher H. , Hayes, John P. , Narayan, Samir , Suh, John H. , Meyer, Joshua E. , Feldman, Marvin, Peterson, Richard A.

The Oncologist | December 16, 2019 | Volume: 25 | Issue: 3 | Pages: e477-e483

10.1634/theoncologist.2019-0562 | PMID 32162826 Get It

AbstractBackgroundSeveral registry-based analyses suggested a survival advantage for married versus single patients with pancreatic cancer. The mechanisms underlying the association of marital status and survival are likely multiple and complex and, therefore, may be obscured in analyses generated from large population-based databases. The goal of this research was to characterize this potential association of marital status with outcomes in patients with resected pancreatic cancer who underwent combined modality adjuvant therapy on a prospective clinical trial.Materials and MethodsThis is an ancillary analysis of 367 patients with known marital status treated on NRG Oncology/RTOG 97-04. Survival analysis was performed using the Kaplan-Meier method and compared using the log-rank test. Multivariate analysis was performed using the Cox proportional hazards regression model.ResultsOf 367 patients, 271 (74%) were married or partnered and 96 (26%) were single. Married or partnered patients were more likely to be male. There was no association between marital status and overall survival (OS) or disease-free survival (DFS) on univariate (hazard ratio [HR], 1.09 and 1.01, respectively) or multivariate analyses (HR, 1.05 and 0.98, respectively). Married or partnered male patients did not have improved survival compared with female or single patients.ConclusionAncillary analysis of data from NRG Oncology/RTOG 97-04 demonstrated no association between marital and/or partner status and OS or DFS in patients with resected pancreatic cancer who received adjuvant postoperative chemotherapy followed by concurrent external beam radiation therapy and chemotherapy. Clinical trial identification number. NCT00003216.